IRIS Archives

Information and Referral and Internet Sightings

IRIS@LISTSERV.ICORS.ORG
Options: Use Forum View

Use Monospaced Font
Show Text Part by Default
Condense Mail Headers

Message: [<< First] [< Prev] [Next >] [Last >>]
Topic: [<< First] [< Prev] [Next >] [Last >>]
Author: [<< First] [< Prev] [Next >] [Last >>]

Print Reply
Content-Transfer-Encoding:
7bit
Sender:
Information and Referral and Internet Sightings <[log in to unmask]>
Subject:
news byte: U.S. Approves Lilly's Cymbalta for Fibromyalgia
From:
Sylvia Caras <[log in to unmask]>
Date:
Mon, 23 Jun 2008 10:41:30 -0700
Content-Type:
text/plain; charset=ISO-8859-1; format=flowed
MIME-Version:
1.0
Reply-To:
[log in to unmask]
Parts/Attachments:
text/plain (12 lines) 
U.S. Approves Lilly's Cymbalta for Fibromyalgia
 From Reuters Health - Jun 16, 2008
NEW YORK (Reuters) - Eli Lilly and Co said Monday its antidepressant 
Cymbalta won U.S. approval for addressing the pain condition 
fibromyalgia, opening up a new market that could propel the drug's 
sales. Pharmaceutical companies have been racing to bring drugs to 
market for fibromyalgia, a sometimes debilitating disorder that affects 
mostly women. Cymbalta's approval follows clearance in fibromyalgia for 
Pfizer's Lyrica.

www.peoplewho.org

ATOM RSS1 RSS2